Tag: Technology

Categories
Healthcare

MJH Life Sciences™ continues moving all live events to virtual through first quarter of 2021

Industry giant will continue to leverage its proprietary online virtual platform and technology through at least March 2021

CRANBURY, N.J.–(BUSINESS WIRE)–#CME–MJH Life Sciences™ confirmed today that all conferences, satellite symposia, award programs and educational programming produced by the privately owned health care media company will take place in virtual format through March 2021.

From the start of the COVID-19 pandemic, MJH Life Sciences™ has adapted existing events and developed new programs to provide timely, critical health care information and education wherever clinicians are.

“Because of our state-of-the-art in-house studio and technology platforms, we were able to pivot successfully to virtual programming right from the start of the COVID-19 lockdown,” said Mike Hennessy Jr., president, and CEO of MJH Life Sciences™. “Events and education are key pillars of how we deliver on our mission to help health care professionals improve quality of life. So, we have taken great care to ensure we are delivering the greatest value, content, and accessibility, all while remaining comfortable and safe. The further upside of our decision is that even more people will be able to experience our events and continuing education without having to decide whether travel is safe enough for them – plus it will help us deliver value to and continue to build our growing global presence.”

Since March, MJH has hosted more than 600 virtual events in various formats, with a combined attendance of over 200,000 health care professionals. Most recently, MJH produced the widely attended and highly rated “COVID-19: A Race for a Vaccine” webinar to help provide clarity and insight about current clinical trials and to address questions regarding distribution of potential COVID-19 vaccines.

The experience gained and lessons learned from producing hundreds of virtual events over the past 4+ months have resulted in knowledge and understanding that will help MJH continue to optimize and perfects its future events. Upcoming large-scale virtual events include Fetch dvm360® Conference, Pharmacy Benefit Management Institute’s 26th Annual National Conference, Physicians’ Education Resource® (PER®), Chemotherapy Foundation Symposium (CFS®), Miami Breast Cancer Conference®, and PTCE’s legacy Directions in Oncology Pharmacy™ and Directions in Pharmacy® spring conference series.

About MJH Life Sciences™

MJH Life Sciences™ is the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH Life Sciences™ combines the reach and influence of its powerful portfolio of digital and print product lines, live events, educational programs and market research with the customization capabilities of a boutique firm. Clients include world-leading pharmaceutical, medical device, diagnostic and biotech companies. For more information, visit https://www.mjhlifesciences.com/.

Contacts

MJH Life Sciences™ Media Contact
Alexandra Ventura, 609-716-7777, ext. 121

aventura@mjhlifesciences.com

Categories
Healthcare

Swittons introduces smart IoT devices for pharmaceutical lab digital transformation initiatives

PISCATAWAY TOWNSHIP, N.J.–(BUSINESS WIRE)–#IoT—Swittons, a P360 company, today announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs. The fully customizable devices align with strategic Lab of the Future (LoTF) initiatives and help automate various laboratory workflows between people and existing digital lab equipment, systems and solutions. Built on an agile technology platform, Swittons devices are easy to deploy within pharmaceutical laboratories of all types.


“There are profound changes taking place in the area of life science research and development,” stated Swittons CEO and Founder Anupam Nandwana. “Driven by technological advances and the development of precision medicines, these modernization initiatives are designed to propel laboratory efficiencies into the future, allowing scientists to spend more time on science. This has changed the very concept of what the lab is, and Swittons is a key part of that evolution.”

The Swittons software platform is designed to provide life sciences companies with a modern, flexible user interface that not only integrates with other systems, but other IoT devices as well. This flexibility gives labs the power to create their own LoTF, configured in the way that works best for their specific use case. This means Swittons devices can be uniquely programmed, even within an individual laboratory, so end users aren’t forced into workflows that don’t fit their job function. In addition, the devices take up very little desk space, so they are conveniently available and work seamlessly within individual work styles.

Swittons devices are designed to be compatible with existing IT systems and integrate with lab support platforms and services such as LIMS, eDOC and ticketing systems. Swittons also features a powerful backend portal and reporting system, where administrators can view user CLICKS in one convenient location. The devices are even able to trigger phone and video calls via a built-in integration with Microsoft Teams.

Each Swittons device can be custom branded, and programmed for a wide range of laboratory scenarios. In pharmaceutical lab settings, Swittons fills the gap between the scientist and the lab by automating functions such as:

  • Trigger equipment maintenance
  • Open equipment service ticket
  • Indicate equipment availability
  • Trigger a video call
  • Notify of temperature control deviation
  • Notify of spill/cleaning needed
  • Equipment occupancy notification
  • Open Tickets in service software such as ServiceNow, Salesforce Service Cloud, Microsoft Dynamics
  • Reorder reagents
  • Re-stock disposable supplies
  • Report OOS or Aberrant result
  • Summon a lab runner
  • Open SOP software
  • Alert in an emergency

Swittons is built on Microsoft Azure, and each device comes out of the box ready and automatically connects through a Wi-Fi or GSM cellular connection. More information about Swittons for LoTF initiatives is available HERE.

Swittons is powered by the technology and expertise developed by P360. Delivering a 360-view through the pharma physician, laboratory and patient ecosystem, P360 designs and deploys capabilities that ensure the highest efficiencies and returns on sales operations, data management, clinical trials, patient centricity and IoT innovation. To learn more about P360, visit P360.com.

About Swittons

Based in Piscataway Township, New Jersey, and powered by P360, Swittons is an end-to-end enterprise IoT solution for commercial acceleration. From dashboard to device to data, Swittons powers seamless engagement. Swittons for physicians and pharma is changing everything about how businesses communicate. To learn more, visit Swittons.com.

Contacts

Brian Fitzgerald

Brian.Fitzgerald@P360.com
808-754-0437

Categories
Healthcare

Zelis announces 30-Year Healthcare Technology Veteran, R. Andrew Eckert, as new chief executive officer

BEDMINSTER, N.J.–(BUSINESS WIRE)–#GPTWcertified–Zelis, the industry’s leading claims cost and payments optimization platform with proprietary technology and solutions to price, pay and explain healthcare claims, announced that R. Andrew Eckert has joined the company as its new Chief Executive Officer. A 30-year veteran of the healthcare technology industry, Eckert has had a lifelong focus on enabling healthcare innovation and leading strong teams to their full potential.


During his career, Eckert has served as CEO of some of the healthcare industry’s most notable and impactful healthcare technology companies, including TriZetto Corporation, Eclipsys Corporation, and Valence Health. In each case, Eckert helped deliver client success, product and technology innovation and strong growth. Immediately prior to joining Zelis, Eckert was the CEO of Acelity, a global advanced wound care company which was sold to 3M in October 2019. Earlier in his career, Eckert served as CEO of CRC Health Group, a leading behavioral health provider owned by Bain Capital, and SumTotal Systems, a leading education technology software company.

Eckert serves on the Board of Directors of Becton Dickinson, a medical technology company, and as Chair of the Board of Directors of Varian Medical Systems, a radiation oncology treatments and software company.

“Zelis’ mission is to optimize the healthcare payments cycle – which we define as pricing, paying and explaining the claim – on behalf of payors, providers and consumers. Andy’s deep experience leading multiple companies that serve Zelis’ core constituencies, combined with his track record of driving outstanding client success, makes him a terrific choice to lead Zelis going forward,” said Dave Ament, Managing Partner of Parthenon Capital.

“I am delighted that Andy is joining Zelis,” said Devin O’Reilly, Managing Director, Bain Capital. “Andy is a highly seasoned CEO and he will help position the company to grow, innovate, and transform our industry.”

“I’m thrilled to be joining Zelis. We are a heavyweight in healthcare technology and are at the epicenter of solving some of the industry’s most intractable challenges. I believe our company will continue to make a huge impact in making the U.S. healthcare system more understandable and affordable,” said Eckert. “I look forward to further building and strengthening the company’s momentum in serving our clients with innovative solutions.”

About Zelis

Zelis is the healthcare industry’s leading claims cost and payments optimization platform with superior technology and solutions to price claims, pay claims and explain claims, all at enterprise scale on a claim-by-claim basis. Zelis leverages proprietary technology, robust analytics, extensive payment and provider networks, and innovative claim savings channels to deliver to the industry superior administrative and medical cost savings. Zelis was founded on a belief that there is a “better way” to determine the cost of a healthcare claim, manage payment related data, and make the claim payment. Zelis provides the industry’s only comprehensive, integrated platform to take a claim through the entire pre-payment to payments lifecycle. Zelis’ ~1000 associates serve more than 700 payor clients, including the top-5 national health plans, Blues plans, regional health plans, TPAs and self-insured employers, and more than 1.5 million providers. Zelis delivers more than $5B of claims savings, $50B of provider payments and 500 million payment data communications annually, and enjoys a highly recurring revenue model and a strong margin profile.

Contacts

Thuy-An Wilkins

Zelis

908.389.8756

Thuy-An.Wilkins@zelis.com

Categories
Business

Merck Animal Health completes acquisition of IdentiGEN

Strategic Transaction Enhances Farm-to-Table Animal Traceability Solutions for Livestock and Aquaculture

MADISON, N.J.–(BUSINESS WIRE)–$MRK #AnimalHealth–Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today announced the completion of its acquisition of IdentiGEN, a leader in DNA-based animal traceability solutions for Livestock and Aquaculture from MML Growth Capital Partners Ireland. Specific terms of the agreement were not disclosed.

IdentiGEN’s technology combines each species’ unique DNA (deoxyribonucleic acid) and data analytics to provide an evidence-based animal traceability solution, called DNA TraceBack®, to accurately and precisely trace beef, seafood, pork and poultry that is verifiable from farm-to-table.

Food producers, processors and retailers are looking for accurate and complete animal traceability solutions that provide full accountability, as well as greater transparency, quality and sustainability of food sources for consumers. The addition of specialized, digital technology within our portfolio of medicines, vaccines and services, provides holistic solutions to help advance animal health and complements our existing identification and monitoring technology that delivers real-time, actionable data and insights to help, improve or enhance animal management and health outcomes.

“Enhanced digital technology will play an increasingly important role in food traceability and food safety, providing customers critical information and actionable data to help ensure a sustainable supply of quality food to protect public health,” said Rick DeLuca, president, Merck Animal Health. “We now will be able to provide end-to-end animal traceability solutions at industry scale to improve the health and safety of animals and ensure even greater transparency in our food supply.”

DeLuca said, “The highly skilled employees at IdentiGEN, led by Ronan Loftus and Ciaran Meghen, exemplify our commitment to The Science of Healthier Animals®, and we look forward to collaborating with the team to leverage our scientific and technical capabilities and expertise to shape the future of animal health.”

In April 2019, Merck Animal Health announced the completion of its acquisition of Antelliq Corporation and its market-leading brands, Allflex Livestock Intelligence, Sure Petcare and Biomark as leaders in emerging digital technology with animal identification, animal monitoring and smart data management for Livestock and Companion Animals. In December 2019, the company acquired Vaki, a leader in fish farming and wild fish conservation monitoring equipment and real-time video monitoring technology to advance fish health and welfare. In June 2020, the company acquired Quantified Ag®, a leading data and analytics company that monitors cattle body temperature and movement in order to detect illness early.

About Merck Animal Health

For more than a century, Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck. Through its commitment to The Science of Healthier Animals®, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on LinkedIn, Facebook, and Twitter at @MerckAH.

About IdentiGEN

IdentiGEN leads the world in delivering DNA-based solutions which shape the future of food trust. Founded in 1996, IdentiGEN is a pioneer of DNA-based solutions for producers, processors and retailers of meat and seafood products in the Agri-food Industry, with operations in Ireland, Europe, the UK and the USA. Our signature product, DNA TraceBack®, helps safeguard and strengthen the integrity of the supply chain for meat, poultry and seafood products through the world’s most accurate and precise traceability platform. A unique solution for industry, using DNA TraceBack® enables beef, pork, poultry and seafood products to be reliably traced back through production to the farm, parent or individual animal from which they originated.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2019 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

Contacts

Merck

Media Contacts:

Jeanette Lewis

+ 1 (973) 294-0318

Jeanette.Lewis@merck.com

Pam Eisele

+1 (267) 305-3558

Pamela.Eisele@merck.com

Merck

Investor Contact:

Michael DeCarbo

+ 1 (908) 740-1807

Michael.DeCarbo@merck.com

Categories
Local News

Universal Display Corporation announces $25,000 donation to the Smith Family Foundation

EWING, N.J.–(BUSINESS WIRE)–$OLED #OLED—Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today announced the donation of $25,000 to the Smith Family Foundation (SFFNJ), a private grant-making institution assisting with education, neighborhood development, youth services, and other community programs in Trenton, NJ.

“The partnership with Universal Display Corporation (UDC) is a wonderful example of how the for-profit and nonprofit communities can work together to create the change we all want to see in our great city,” said Katherine Nunnally, Executive Director and Chief Executive Officer of the Smith Family Foundation. “Through our relationship, the Trenton nonprofit sector will be allocated resources and educational opportunities to assist them as they continue working to make our community a safe, healthy, and prosperous urban hub.”

“We are committed to fostering our local communities and are pleased to be supporting the Smith Family Foundation with this donation of $25,000,” said Steven V. Abramson, President and Chief Executive Officer of Universal Display Corporation. “Our relationship with the Smith Family Foundation began with Steve Smith, a former UDC colleague and current SFFNJ Board Member, and we are delighted to continue working together on a mission to enrich the Trenton community through educational initiatives.”

About Smith Family Foundation

The Smith Family Foundation is a private grant-making Institution, founded in Trenton, NJ in 2016. Their Mission is to empower its community, cultivate leaders and transform lives by providing funding and leadership development to Trenton-based organizations.

In May of 2016, the Smith family — Pearlie Smith & her seven children — received a substantial financial blessing. Blessed with a new opportunity, the family made it their collective mission to improve the quality of life for residents in their hometown – thus the Smith Family Foundation was born. While the foundation allows the Smiths to support their community in ways previously unimagined, the family is no stranger to philanthropy. The seeds for the foundation were planted decades ago in the South Side of Trenton, where Seamon and Pearlie Smith raised their children on values of hard work, love of God, and giving back.

About Universal Display Corporation

Universal Display Corporation (Nasdaq: OLED) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. Founded in 1994, the Company currently owns, exclusively licenses or has the sole right to sublicense more than 5,000 patents issued and pending worldwide. Universal Display licenses its proprietary technologies, including its breakthrough high-efficiency UniversalPHOLED® phosphorescent OLED technology that can enable the development of low power and eco-friendly displays and solid-state lighting. The Company also develops and offers high-quality, state-of-the-art UniversalPHOLED materials that are recognized as key ingredients in the fabrication of OLEDs with peak performance. In addition, Universal Display delivers innovative and customized solutions to its clients and partners through technology transfer, collaborative technology development and on-site training.

Headquartered in Ewing, New Jersey, with international offices in China, Hong Kong, Ireland, Japan, South Korea and Taiwan, and wholly-owned subsidiary Adesis, Inc. based in New Castle, Delaware, Universal Display works and partners with a network of world-class organizations. To learn more about Universal Display Corporation, please visit https://oled.com/.

Universal Display Corporation and the Universal Display Corporation logo are trademarks or registered trademarks of Universal Display Corporation. All other company, brand or product names may be trademarks or registered trademarks.

All statements in this document that are not historical, such as those relating to the impact of the COVID-19 pandemic on the Company and otherwise, Universal Display Corporation’s technologies and potential applications of those technologies, the Company’s expected results and future declaration of dividends, as well as the growth of the OLED market and the Company’s opportunities in that market, are forward-looking financial statements within the meaning of the Private Securities Litigation Reform Act of 1995. You are cautioned not to place undue reliance on any forward-looking statements in this document, as they reflect Universal Display Corporation’s current views with respect to future events and are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated. These risks and uncertainties are discussed in greater detail in Universal Display Corporation’s periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, including, in particular, the section entitled “Risk Factors” in Universal Display Corporation’s Annual Report on Form 10-K for the year ended December 31, 2019 and its subsequent Quarterly Reports on Form 10-Q. Universal Display Corporation disclaims any obligation to update any forward-looking statement contained in this document.

Follow Universal Display Corporation

Twitter
Facebook
YouTube

(OLED-C)

Contacts

Universal Display:

Darice Liu

investor@oled.com
media@oled.com
+1 609-964-5123

Smith Family Foundation Inc.:

Katherine N. Nunnally, MPA

Executive Director/CEO

knunnally@sffnj.org
+1 609-888-6300

Categories
Business

Protective Insurance selects Majesco P&C Core Suite for Commercial Auto and Workers’ Compensation lines of business on Majesco CloudInsurer® to accelerate their digital transformation

Leading provider of insurance for the transportation industry executes its vision of a new digital business model by replacing legacy systems from three different vendors with Majesco’s next-generation solutions

MORRISTOWN, N.J.–(BUSINESS WIRE)–Majesco (NASDAQ: MJCO), a global leader of cloud insurance software, today announced that Protective Insurance selected Majesco P&C Core Suite for Commercial Auto and Workers’ Compensation claims and billing solutions on Majesco CloudInsurer® to replace legacy solutions and modernize and optimize their business operation and accelerate their digital transformation strategy.

With more than 90 years of experience, Protective Insurance Company specializes in providing insurance for the transportation industry. Licensed in all 50 states, the District of Columbia, Puerto Rico and all Canadian provinces, Protective provides tailored insurance programs to trucking fleets. Its products are backed by a dedicated safety services team, experienced claims management and superior customer service.

“We’re committed to modernizing our existing systems by bringing innovative, business solutions to the cloud. This technology transformation will give us the flexibility to make the right decisions; to pivot our direction with minimal impact to our business,” said Jeremy Johnson, CEO of Protective Insurance. “After a detailed and careful selection process, Majesco stood out with a core suite that delivers advanced capabilities, user-friendly functionality, mature cloud platform that integrates with the transformation program already underway, and a track record of rapid and successful delivery that will help accelerate our digital transformation and vision for the future of insurance.”

Key to the selection was Majesco’s next-generation core suite with out-of-the-box capabilities, robust functionality and flexible configuration, strong roadmap, mature cloud platform, and a track record of rapid and successful delivery that directly aligned with Protective’s vision of creating a new business model that better serves today’s digital-focused customer. The ability to easily leverage data from Majesco’s systems combined with the configurability and functionality of its core suite will be crucial to fuelling their strategy for innovation and growth. The first phase of the project will focus on commercial auto followed by a second phase that will implement workers’ compensation.

“Protective’s digital business vision is very much aligned with Majesco’s vision, making this partnership seamless from the start,” says Adam Elster, CEO of Majesco. “Our SaaS and Cloud core platforms have become the de-facto software-delivery model for insurance, and we’re thrilled Protective has chosen Majesco to help keep them at the forefront of the industry and lead in this new era of insurance.”

About Majesco

Majesco (NASDAQ: MJCO) provides technology, expertise, and leadership that helps insurers modernize, innovate and connect to build the future of their business – and the future of insurance – at speed and scale. Our platforms connect people and businesses to insurance in ways that are innovative, hyper-relevant, compelling and personal. Over 200 insurance companies worldwide in P&C, L&A and Group Benefits are transforming their businesses by modernizing, optimizing or creating new business models with Majesco. Our market-leading solutions include CloudInsurer® P&C Core Suite (Policy, Billing, Claims); CloudInsurer® LifePlus Solutions (AdminPlus, AdvicePlus, IllustratePlus, DistributionPlus); CloudInsurer® L&A and Group Core Suite (Policy, Billing, Claims); Digital1st® Insurance with Digital1st® Engagement, Digital1st® EcoExchange and Digital1st® Platform – a cloud-native, microservices and open API platform; Distribution Management, Data and Analytics and an Enterprise Data Warehouse. For more details on Majesco, please visit www.majesco.com.

Cautionary Language Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Majesco’s reports that it files from time to time with the Securities and Exchange Commission and which you should review, including those statements under “Item 1A – Risk Factors” in Majesco’s Annual Report on Form 10-K, as amended by its Quarterly Reports on Form 10-Q.

Important factors that could cause actual results to differ materially from those described in forward-looking statements contained in this press release include, but are not limited to: the adverse impact on economies around the world and our customers of the current COVID-19 pandemic; our ability to achieve increased market penetration for our product and service offerings and obtain new customers; our ability to raise future capital as needed; the growth prospects of the property & casualty and life & annuity insurance industry; the strength and potential of our technology platform and our ability to innovate and anticipate future customer needs; our ability to compete successfully against other providers and products; data privacy and cyber security risks; technological disruptions; our ability to successfully integrate our acquisitions and identify new acquisitions; the risk of loss of customers or strategic relationships; the success of our research and development investments; changes in economic conditions, political conditions and trade protection measures; regulatory and tax law changes; immigration risks; our ability to obtain, use or successfully integrate third-party licensed technology; key personnel risks; and litigation risks.

These forward-looking statements should not be relied upon as predictions of future events and Majesco cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by Majesco or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this presentation. Majesco disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this press release or to reflect the occurrence of unanticipated events, except as required by law.

Contacts

Laura Tillotson

Director, Marketing Communications and Creative Services

+ 201 230 0752

laura.tillotson@majesco.com

Categories
Business

NICE Satmetrix Benchmark finds 57% of contact center employees working from home due to COVID-19 are now more likely to recommend employer

However, 71% of contact center managers say the shift to work at home has had a significant impact on customers

HOBOKEN, N.J.–(BUSINESS WIRE)–NICE (Nasdaq: NICE) today announced that the NICE Satmetrix Agent Experience at Home Benchmark found that 57% of contact center employees working from home due to COVID-19 are now more likely to recommend their employers to friends, family, or peers than they were before the transition to working remotely. However, in contrast to this positive impact on employee Net Promoter Score (eNPS), 71% of contact center managers say that their organization’s shift to work at home has had a significant impact on customers.

With the transition to remote work environments, today’s customer service managers and their teams are dealing with multiple challenges all at once, including increased interaction volume across all channels; longer handle times, as service interactions become the first line of support for distressed consumers; more demanding customer needs, as agents are dealing with new, unusual requests that are more complex and sometimes outside their direct control; and a new remote work methodology.

NICE Satmetrix co-founded NPS and is a trusted source for data and insights used to improve customer satisfaction, loyalty, and advocacy, and reduce customer churn. The NICE Satmetrix Agent Experience at Home Benchmark identified three key drivers that improved eNPS that organizations can apply to increase employee engagement:

  • Providing the Right Tools and Technology
  • Communicating Effectively
  • Taking Quick Action for Employees

To address these challenges, NICE has recently introduced CXone@home to enable the safe transition of contact center agents to work from home within hours, for organizations of all sizes and verticals. It is powered by the market-leading CXone cloud contact center platform and is offered at no charge for 60 days for new customers. Purpose-built for remote workforces, CXone@home also includes a complete suite of workforce engagement and optimization (WFO) capabilities – including quality and coaching with analytics, performance management, and workforce forecasting and scheduling – to ensure agents and managers are productive while working from home. The demand for CXone@home has been unprecedented by organizations of all sizes with legacy on-premises infrastructures. NICE also recently launched WEM@home and NEVA@home to drive immediate impact on service excellence for work at home employees.

“NICE is pleased to make possible the quick transition to work at home for thousands of contact center agents and managers,” said Barry Cooper, NICE Enterprise Group President. “Many organizations that have shifted to work from home now face challenges of engaging and ensuring performance of their newly remote and dispersed workforce, while at the same time the nature and volume of the work are rapidly changing. These same organizations have requested CXone@home to help them deal with these challenges.”

Mr. Cooper added, “COVID-19 is changing how people work and organizations operate. Companies are adapting in order to ensure business continuity, employee engagement, and performance. NICE is dedicated to empowering exceptional customer service in times of change.”

As the leading cloud platform for contact centers, CXone has a global, geographically redundant cloud infrastructure with built-in elasticity to dynamically scale up or down based on demand. NICE inContact proactively monitors and continuously forecasts demand with reserves for immediate spikes in volume and the ability to add data and storage capacity immediately. Customers can rely on the 99.99% guaranteed availability on carrier-grade network with global data centers and points of presence (POPs) as well as 24/7/365 network operations monitoring. Contact center agents using NICE inContact CXone are operating in over 100 countries.

About the NICE Satmetrix Agent Experience at Home Benchmark

In response to COVID-19, thousands of contact center agents are now working from home, helping meet customer needs across the globe. NICE Satmetrix fielded a groundbreaking benchmark to help organizations better understand agent experience at home and learn how to proactively improve that experience while powering exceptional customer experience. Organizations interested in fielding the survey at no cost to their teams, in order to compare themselves to the benchmark, may register here.

NICE Satmetrix gives enterprises the power to unlock the value of CX data and insights – across the holistic customer journey from the contact center and beyond – to increase customer satisfaction, loyalty, and advocacy and reduce customer churn. A holistic, unified, and integrated Customer Experience Management (CEM) solution, NICE Satmetrix delivers actionable customer experience insights to roles across the organization that are dynamic, predictive, and prescriptive. NICE Satmetrix co-founded NPS and built its complete solution from the ground up to operationalize customer feedback insights all along the customer journey.

About NICE

NICE (Nasdaq: NICE) is the world’s leading provider of both cloud and on-premises enterprise software solutions that empower organizations to make smarter decisions based on advanced analytics of structured and unstructured data. NICE helps organizations of all sizes deliver better customer service, ensure compliance, combat fraud and safeguard citizens. Over 25,000 organizations in more than 150 countries, including over 85 of the Fortune 100 companies, are using NICE solutions. www.nice.com.

Trademark Note: NICE and the NICE logo are trademarks or registered trademarks of NICE Ltd. All other marks are trademarks of their respective owners. For a full list of NICE’s marks, please see: www.nice.com/nice-trademarks.

Forward-Looking Statements

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements, including the statements by Mr. Cooper, are based on the current beliefs, expectations and assumptions of the management of NICE Ltd. (the “Company”). In some cases, such forward-looking statements can be identified by terms such as “believe,” “expect,” “seek,” “may,” “will,” “intend,” “should,” “project,” “anticipate,” “plan,” “estimate,” or similar words. Forward-looking statements are subject to a number of risks and uncertainties that could cause the actual results or performance of the Company to differ materially from those described herein, including but not limited to the impact of changes in economic and business conditions, including as a result of the COVID-19 pandemic; competition; successful execution of the Company’s growth strategy; success and growth of the Company’s cloud Software-as-a-Service business; changes in technology and market requirements; decline in demand for the Company’s products; inability to timely develop and introduce new technologies, products and applications; difficulties or delays in absorbing and integrating acquired operations, products, technologies and personnel; loss of market share; an inability to maintain certain marketing and distribution arrangements; the Company’s dependency on third-party cloud computing platform providers, hosting facilities and service partners;, cyber security attacks or other security breaches against the Company; the effect of newly enacted or modified laws, regulation or standards on the Company and our products and various other factors and uncertainties discussed in our filings with the U.S. Securities and Exchange Commission (the “SEC”). For a more detailed description of the risk factors and uncertainties affecting the company, refer to the Company’s reports filed from time to time with the SEC, including the Company’s Annual Report on Form 20-F. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no obligation to update or revise them, except as required by law.

Contacts

Corporate Media
Christopher Irwin-Dudek, 201-561-4442, chris.irwin-dudek@nice.com

Investors
Marty Cohen, +1 551 256 5354, ET, ir@nice.com
Yisca Erez +972 9 775 3798, CET, ir@nice.com

Categories
Business

Tegra118’s RetireUp adds Protective Life Insurance Company to growing roster of insurance carriers

Builds momentum in solving for retirement and lifetime income needs by continuing to add products from top-tier insurance carriers on its comprehensive platform

WARREN, N.J.–(BUSINESS WIRE)–Tegra118, a top provider of wealth and asset management technology solutions, announced that its recently acquired RetireUp business has added Protective® Income Builder indexed annuity from Protective Life Insurance Company to its extensive lineup of modeled products available on its RetireUp Pro platform.

Tegra118’s leading RetireUp Pro platform allows financial professionals to transform complex concepts into simple numbers engaging visuals and real-life “what if” scenarios. With its ability to model insurance products at the actuarial level directly within the client’s portfolio, Tegra118’s RetireUp Pro enables financial professionals to easily demonstrate the potential benefits of incorporating annuities into a retirement plan for a holistic and personalized approach to the overall financial planning process.

“Tegra118’s RetireUp Pro is a vital tool to help engage clients in the financial planning process, simplify retirement income planning and provide a more personalized approach,” said Jim Wagner, Senior Vice President and Chief Distribution Office, Protective Life. “Including our products on a dynamic platform that enables financial professionals to look at the interconnectivity of risk and retirement to better advise their clients aligns well with our mission of helping people protect their tomorrow so they can embrace today.”

“Protective’s alliance with Tegra118’s RetireUp helps elevate the advisor-client conversation by providing a best-in-class income product,” said Michael Roth, the new Head of Retirement at Tegra118. “Solving for lifetime income in retirement is a complex problem that is unique to each retiree and our technology solves this by continuously adding innovative retirement solutions and modelling them through a user interface that is easy to understand.”

“We’re excited to work with Protective and bring their high-quality income and annuity products on our platform,” said Cheryl Nash, Chief Executive Officer, Tegra118. “One of the ways we demonstrate value to our clients is by working with the highest-rated insurance companies to give financial professionals even greater options in creating personalized, customized income solutions. Protective’s products meet that criteria and help demonstrate the benefits of adding annuities to a financial plan.”

RetireUp’s nimble and efficient software and simulations make it easy for financial professionals to assess a client’s needs for specific lifetime income products by translating complex financial concepts into easy-to-understand “big-picture” visuals, enabling them to help investors become active participants in their own financial futures.

About Protective Life Corporation

Protective Life Corporation (Protective) provides financial services through the production, distribution and administration of insurance and investment products throughout the U.S. Protective traces its roots to its flagship company, Protective Life Insurance Company – founded in 1907. Throughout its more than 110-year history, Protective’s growth and success can be largely attributed to its ongoing commitment to serving people and doing the right thing – for its employees, distributors, and most importantly, its customers. Protective’s administrative office is located in Birmingham, Alabama, and its 3,000+ employees are located in offices across the United States. As of December 31, 2019, Protective had assets of approximately $120 billion. Protective Life Corporation is a wholly owned subsidiary of Dai-ichi Life Holdings, Inc. (TSE:8750). For more information about Protective, please visit www.Protective.com.

About Tegra118

Tegra118 is an industry leading provider of software solutions to the wealth and asset management industry with a vast network of broker-dealers, asset managers, and custodians and trading interfaces. Its technology platform provides portfolio management, trading, accounting, rebalancing and reporting for managed accounts. Tegra118 also provides modular, goals-based financial planning, performance reporting and fee billing software for financial advisors and asset managers using modern API-based open technology. Tegra118 is committed to delivering powerful solutions that set a new standard for how people interact with, manage, and grow their wealth.

Tegra118 is a Motive Partners company, a specialist private equity firm with offices in New York City and London, focused on technology-enabled business and financial services companies. For more information, please visit www.tegra118.com.

Contacts

Media Relations:
Tricia Viola

Vice President, Marketing

Tegra118

201 253 3389

tricia.viola@fiserv.com

Categories
Business

Topcon acquires Henson perimeter business

Company Adds Leading Perimetry Screening Devices to Its Global Product Portfolio

NEWBURY, United Kingdom–(BUSINESS WIRE)–#SeeingEyeHealthDifferently–Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has acquired the Henson line of perimetry products, including the Henson 9000 and 7000, from Elektron Eye Technology (EET) of Cambridge, UK.


The acquisitions include the transfer of a number of EET staff to Topcon’s team. Manufacturing will continue in the UK as it has throughout the years past.

The Henson line of perimetry products are well regarded in the eye care industry for their accuracy, speed and ease of use. The Henson 9000 is the ideal perimeter for the early detection of glaucoma and the ongoing monitoring of established loss, while the Henson 7000 is an affordable, lightweight, mobile perimeter designed to perform suprathreshold glaucoma screening in the central field.

Mr. John Trefethen, Global VP of Marketing & Product Design for Topcon Healthcare commented, “The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio. With Topcon’s growing emphasis on screening and early disease detection, the Henson product range perfectly complements our global strategy. I welcome the EET team members to the Topcon Healthcare Family.”

Mr. Trefethen continued, “As the global rate of glaucoma continues to rise, Topcon is pleased to incorporate the award-winning Henson perimeters into our brand portfolio. We look forward to working with Professor Henson and the talented team from EET to further develop this innovative product line, bringing critical glaucoma screening, monitoring and early disease detection tools to the global eye care community. Topcon’s mission remains the same, to enable greater and greater access to healthcare providers in all faucets of disease detection and diagnosis. We remain fully committed to the continued development of medical devices and software platforms that allow today’s eye care providers to practice smarter, safer and more efficiently, including our screening, automated and remote diagnostics solutions.”

For more information on Topcon Healthcare, please visit www.topconhealth.com.

About Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever- changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing and ground-breaking remote diagnostic technology.

A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.

About Elektron Eye Technology (EET)

Elektron Eye Technology (Cambridge, UK) is a subsidiary of Elektron Technology and home to spectrum of world-class fast-moving engineered product (FMEP) brands, including the Henson Perimeters and the Macular Pigment Screener (MPS II). They are the ophthalmic instruments of choice for eye care professionals involved in the screening and monitoring of glaucoma and age-related macular degeneration (AMD). Designed in partnership with respected eye care professionals, their accuracy, efficiency and ease of use ensures that they meet the needs of optometrists and ophthalmologists, as well as the patients they work with every day.

Contacts

John Trefethen, MFA

Global Vice President, Marketing & Product Design Topcon Healthcare

E-mail: jtrefethen@topcon.com

Categories
Digital - AI & Apps

Pluses, perils of social media

Today’s society is one that involves lightning fast communications, an overwhelming presence of the Internet, and social media platforms that affect everyday life all over the world.

No longer do you have to wait days for a letter to arrive in the mail, or speak to your friends over the phone in order to catch up. The Internet and social media now allow for people to send emails anywhere, reach out to friends that are thousands of miles away, and more.

There are several positive aspects of social media. However, social media has negative consequences if not appropriately balanced.

Image source: Pixabay - Individuals are fascinated with social media, but struggle to find a balance when using the different aspects of the media that have taken over everyday lives.
Image source: Pixabay –
Individuals are fascinated with social media, but struggle to find a balance when using the different aspects of the media that have taken over everyday lives.

One of the perks of social media also brings to light a negative consequence. With the ability to see what your friends, families, and followers are doing instantly you become attached and feel included. This introduces a false sense of connection that can actually be socially detrimental depending on how a person handles it. Social media should be used to enhance your connections with people, but by solely relying on it, you can quickly acquire a false sense of friendship and interaction.

Brian Jung writes about The Negative Effect of Social Media on Society and Individuals, where he discusses the delusions that are created by social media platforms. He poses a strong argument in pointing out that the relationships reliant on social media are often fake and that social media often times make it difficult for a person to differentiate genuine and hollow relationships

Ali Kingston Mwila also conveyed the positives and negatives of social media. He talks directly about how social media sites can be used effectively to build business relationships and also allow businesses to interact directly with their customers.

Mwila writes the Positive and Negative Effects of Social Media on Society, and the article is a reference point for those wanting to research the influences of social media as the platforms continue to grow.

Both sides of this argument are important when considering how to balance your personal experiences with social media.

Writer, Damon Beres published 5 Weird Negative Effects of Social Media on Your Brain, which studies how social media can affect your buying habits, appetite, and opinions on many topics.

His article emphasizes the importance of consuming media with caution because free- thinking and being true to one’s self are very important. Beres is aware that the huge influence of social media can affect self-esteems, opinions, and more, in the same way that various news outlets can sway the angle of a story in order to portray a way of thinking.

Technology and social media are amazing and can be implemented in everyday life. They have tons of benefits, like faster communication, creating friendships, enhancing businesses, and more. However, always be cautious in the ways that you allow social media to influence your thinking. Being an independent and confident thinker is much more important than how many followers you have online.